Profile
HKPD ONC WBA DFTX HROWL HROWM
Company Name Cellyan Biotechnology Co., Ltd BeOne Medicines Ltd. Walgreens Boots Alliance, Inc. Definium Therapeutics, Inc. Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 11.875% Senior Notes due 2027
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals
Market Cap $9.10M $37.82B $10.37B $1.64B $1.37B $1.34B
Employees 0.03K 11.00K 193.00K 0.07K 0.22K 0.22K
CEO Chenyu Liang John V. Oyler Timothy C. Wentworth Robert Barrow Mark L. Baum Mark L. Baum
Ratings
HKPD ONC WBA DFTX HROWL HROWM
Quant Rating Score 2 2 2 1 1 1
Quant Rating Sell Sell Sell Strong Sell Strong Sell Strong Sell
Trading
HKPD ONC WBA DFTX HROWL HROWM
Last Close $1.18 $376.63 $11.98 - $25.61 $26.03
High 52 $2.89 $377.81 $12.93 - $25.72 $26.95
Low 52 $0.88 $175.1 $8.24 - $25.01 $25.85
Price vs. 52 Week High -59.17 % -0.31 % -7.35 % - -0.43 % -3.41 %
Price vs. 52 Week Low 34.09 % 115.09 % 45.39 % - 2.4 % 0.7 %
Total Return
HKPD ONC WBA DFTX HROWL HROWM
1 Month Return 0 % 19.03 % 0 % - 0 % 0 %
3 Month Return 8.26 % 17.95 % -0.17 % - 0.55 % -1.33 %
6 Month Return 15.7 % 64.91 % 6.11 % - 1.23 % -0.78 %
9 Month Return -43.27 % 58 % 8.32 % - 1.13 % -2.87 %
YTD Return 0 % 104.69 % 28.4 % - 1.32 % -0.69 %
1 Year Return 0 % 0 % 44.51 % - 1.31 % -1.03 %
3 Year Return 0 % 0 % 0 % - 0 % 0 %
5 Year Return 0 % 0 % 0 % - 0 % 0 %
Dividends
HKPD ONC WBA DFTX HROWL HROWM
Dividend Yield Percentage (TTM) - - - - - -
Dividend Paid and Capex Coverage Ration (TTM) 8.14 % 2.45 % 0.96 % - 0.46 % 0.46 %
Dividend Per Share (TTM) - - - - - -
Payout Ratio (TTM) - - -10.29 % - - -
Growth
HKPD ONC WBA DFTX HROWL HROWM
Asset Growth 8.65 % 1.99 % -16.14 % 24.77 % 24.77 %
Gross Profit Growth -32.13 % 54.71 % -2.02 % 66.06 % 66.06 %
Revenue Growth 21.72 % 54.96 % 6.17 % 53.32 % 53.32 %
Revenue 3 Year 97.26 % 185.46 % 11.65 % 106.71 % 106.71 %
Revenue 5 Year 97.26 % 407.52 % 31.29 % 177.12 % 177.12 %
Revenue 10 Year 97.26 % 14520 % 113.45 % 2980.55 % 2980.55 %
EBIT Growth -91.68 % 52.95 % -183.88 % 1018.99 % 1018.99 %
Net Income Growth -102.03 % 26.87 % -180.39 % 28.39 % 28.39 %
Net Income 3 Yeari Growth Per Share -103.3 % 61.02 % -440.4 % 27.14 % 27.14 %
Net Income 5 Yeari Growth Per Share -103.3 % 61.23 % -331.55 % -7491.01 % -7491.01 %
Net Income 10 Yeari Growth Per Share -103.3 % -1664.38 % -593.61 % 55.74 % 55.74 %
Operating Income Growth -91.79 % 52.95 % -104.53 % 1946.87 % 1946.87 %
Operating Cash Flow Growth (CFG) 244.35 % 87.85 % -54.92 % -678.18 % -678.18 %
Operating 3 Year CFG -59.81 % 90.46 % -81.64 % -427.89 % -427.89 %
Operating 5 Year CFG -59.81 % 89.31 % -80.57 % -1760.03 % -1760.03 %
Operating 10 Year CFG -59.81 % -709.03 % -71.12 % 19.39 % 19.39 %
EPS Growth -101.5 % 27.57 % -180.39 % 34.67 % 34.67 %
EPS Diluted Growth -101.67 % 27.57 % -180.39 % 34.67 % 34.67 %
Book Value Per Share -4.23 % -6.6 % -57.24 % -9.43 % -9.43 %
Share Holder 3 Year Equity Growth Per Share 939.56 % -52.12 % -56.07 % 363.19 % 363.19 %
Share Holder 5 Year Equity Growth Per Share 939.56 % 97.53 % -53.83 % 78.54 % 78.54 %
Share Holder 10 Year Equity Growth Per Share 939.56 % 6367.84 % -43.9 % 118.93 % 118.93 %
Dividend Per Share Growth - - -24.04 % - -
Dividend 3 Year Growth Per Share - - -21.92 % -100 % -100 %
Dividend 5 Year Growth Per Share - - -18.12 % - -
Dividend 10 Year Growth Per Share - - 16.05 % - -
Debt Growth 13.8 % 16.09 % 0.7 % 20.12 % 20.12 %
Free Cash Flow Growth 185.88 % 61.81 % -357.45 % 59.06 % 59.06 %
Updated On 31 Mar 2025 31 Dec 2024 31 Aug 2024 31 Dec 2024 31 Dec 2024
Profitability
HKPD ONC WBA DFTX HROWL HROWM
Gross Profit Margin TTM 11.89 % 86.11 % 17.13 % - 74.56 % 74.56 %
Return on Assets TTM -0.29 % 1.06 % -9.07 % -70.95 % -1.37 % -1.37 %
Return on Equity TTM -0.52 % 2.19 % -70.17 % -86.18 % -8.96 % -8.96 %
Return on Capital Employed TTM 2.03 % 3.06 % -7.17 % -88.16 % 9.35 % 9.35 %
Net Income Per EBT TTM -74.92 % 39.97 % 107.6 % 100 % 90.66 % 90.66 %
EBT Per Ebit TTM 27.35 % 125.31 % 187.84 % 111.18 % -19.78 % -19.78 %
EBIT Per Revenue TTM 0.65 % 3.2 % -2.02 % - 11.13 % 11.13 %
Cash Flow To Debt Ratio TTM 23.97 % 77 % 5.43 % - 7.02 % 7.02 %
Receivables Turnover TTM 4.31 5.83 23.42 - 3.21 3.21
Payables Turnover TTM 10.36 1.82 9.41 - 3.35 3.35
Inventory Turnover TTM 31.96 1.31 17.5 - 4.96 4.96
Fixed Asset Turnover TTM 3421.37 % 284.64 % 556.84 % - 2202.82 % 2202.82 %
Asset Turnover TTM 215.71 % 65.95 % 222.72 % - 68.87 % 68.87 %
Operating Cash Flow Per Share TTM 0.05 7.13 1.82 -1.33 0.48 0.48
Free Cash Flow Per Share TTM 0.05 4.22 0.67 -1.33 -0.55 -0.55
Cash Per Share TTM 29.04 % 3662.7 % 95.96 % 243.43 % 200 % 200 %
Operating Cash Flow Sales Ratio TTM 2.8 % 15.6 % 1.02 % - 7.07 % 7.07 %
Free Cash Flow Operating Cash Flow Ratio TTM 87.72 % 59.15 % 36.78 % 100 % -115.84 % -115.84 %
Cash Flow Coverage Ratios TTM 23.97 % 77 % 5.43 % - 7.02 % 7.02 %
Price To Free Cash Flows Ratio TTM 18.22 88.39 17.88 -14.42 -85.37 -85.6
Price To Operating Cash Flows Ratio TTM 15.04 5.51 6.57 -12.74 99.18 99.45
Price Cash Flow Ratio TTM 15.04 5.51 6.57 -12.74 99.18 99.45
Income Statement (TTM)
HKPD ONC WBA DFTX HROWL HROWM
Revenue $0.02B $3.81B $147.66B $0B $0.2B $0.2B
Gross Profit $0B $3.22B $26.52B $-0B $0.15B $0.15B
Gross Profit Ratio 11.89% 84.41% 17.96% 0% 75.33% 75.33%
EBITDA $0B $-0.4B $-11.28B $-0.11B $0.02B $0.02B
Net Income $-0B $-0.64B $-8.64B $-0.11B $-0.02B $-0.02B
EPS Diluted - -6.12 -10.01 -0.15 -0.49 -0.49
Balance Sheet (MRQ)
HKPD ONC WBA DFTX HROWL HROWM
Long Term Debt $0B $0.21B $29.88B $0.02B $0.23B $0.23B
Total Liabilities $0B $2.59B $68.86B $0.06B $0.32B $0.32B
Total Equity $0B $3.33B $12.18B $0.24B $0.07B $0.07B
Total Investments $0B $0.13B $4.06B $0B $0B $0B
Total Debt $0B $1.08B $33.77B $0.02B $0.23B $0.23B
Total Assets $0.01B $5.92B $81.04B $0.3B $0.39B $0.39B
Cash Flow Statement (TTM)
HKPD ONC WBA DFTX HROWL HROWM
Net Income $-0B $-0.64B $-15.45B $-0.11B $-0.02B $-0.02B
Inventory $0B $-0.09B $-0.03B $0B $0B $0B
Dividends Paid $0B $0B $-1.26B $0B $0B $0B
Operating Cash Flow $0B $-0.14B $1.02B $-0.08B $-0.02B $-0.02B
Capital Expenditure $-0B $-0.53B $-1.38B $0B $-0.04B $-0.04B
Related Stocks
Ticker Name Price
AIXC Qualigen Therapeutics, Inc. 1.415
ATAI Atai Life Sciences N.V. 3.94
ATNFW CannBioRx Life Sciences Corp. 0.43
BGMS Bio Green Med Solution, Inc. 1.01
BGMSP Bio Green Med Solution, Inc. 3.72
BIMI BIMI International Medical Inc. 0.0001
CGEM Cullinan Oncology, Inc. 11.825
CJJD China Jo-Jo Drugstores, Inc. 1.52
DFTX Mind Medicine (MindMed) Inc. 17.34
HITI High Tide Inc. 2.425
HROWL Harrow Health, Inc. 8.625% Senior Notes due 2026 25.61
HROWM Harrow Health, Inc. 11.875% Senior Notes due 2027 26.03
KYNB FibroGen, Inc. 7.945
LFLY Leafly Holdings, Inc. 37
LFLYW Leafly Holdings, Inc. 0.004
LFMD LifeMD, Inc. 3.195
LFMDP LifeMD, Inc. 22.3
MDVL MedAvail Holdings, Inc. 1.8
MEDS TRxADE HEALTH, Inc. 7.59
MSLE Satellos Bioscience Inc. Common Stock 10.99
Unlock